Surgeons at the University of Michigan Kellogg Eye Center performed the first bionic eye surgeries in January, a little less than a year after the U.S. Food and Drug Administration (FDA) approved the Argus II retinal implant device. The Kellogg Eye Center is one of 12 facilities in the U.S. offering bionic eye surgery.
The device was designed to replicate certain functions of the retina for patients suffering from retinitis pigmentosa. While Argus II will not completely restore a patient’s vision, researchers and surgeons expect that patients “will be able to see objects, or lights in front of them,” Kellogg Eye Center surgeon Dr. Thiran Jayasundera told WZZM13.
However, those results will not be immediate. Patients must first fully recover from the implant procedure, and then doctors will activate the patient’s bionic eye. Afterwards, patients will go through one to three months of training to help them adapt to their new bionic eye and new vision capabilities. Dr. Jayasundera said the training will help each patients’ brain “learn to sort through the many impulses that are stimulated when recipients turn their head in different directions.”
Linda S., the first patient to receive the surgery, is hopeful …![]()